Shandong Yuantai Bioengineering Co., Ltd. (Yuantai Bioengineering), founded in June 2014, is a joint-stock high-tech Bioengineering Co., Ltd., with a registered capital of 25.85 million yuan, and its legal address is No. 398 Huai'an Road, economic development zone, Rizhao City, Shandong Province.The company plans to cover an area of 58696 square meters (88 mu). At present, phase I and phase II projects cover a total area of about 38000 square meters and a construction area of more than 20000 square meters. The company's investment in phase II projects totals 190 million yuan. Phase I project has been completed and put into operation in August 2016, and phase II project is expected to be completed and put into operation in the first half of 2019.The company is committed to the R & D, production and operation of biological food additives. At present, its main products include nisin, natamycin and TG enzyme (glutamine aminotransferase). These are recognized green, healthy and safe biological food additives, which are used for anti-corrosion, preservation and stability processing of all kinds of food. The products are widely supplied to domestic and foreign markets, Meet the urgent needs of the downstream food industry and the public for food health and safety.The registered trademark of Yuantai biology is "" and the first product nisin was listed in early March 2017. Over the past two years, the company's brand products have won high praise in the market with excellent quality, intimate and professional technical services and ultra-high cost performance. The product sales volume has been expanding and the market share has gradually increased. It has become one of the main manufacturers of biological food additives in China, "Yuantaibao" brand has been widely recognized by the market.The company has a complete public engineering system and independent wastewater treatment facilities, with a daily treatment capacity of 1500 cubic meters. After environmental protection treatment, the production sewage is discharged into the municipal sewage treatment plant in the biomedical park (with a daily treatment capacity of 60000 cubic meters). This set of environmental protection facilities can fully meet the requirements of the company's production capacity.The company has an independent R & D Center (academician workstation of Shandong Province), and the academician team of national key talent engineering experts continues to improve the technical level of existing products and research and development of new products and technologies, ensuring the leading technical level of the company and continuously improving the market competitiveness of products.The company has a holding subsidiary, Shandong Yinghe Biotechnology Co., Ltd., which is a joint venture with China Pharmaceutical University. The company plans to cover an area of 126.6 mu, including 71.6 mu in phase I and 55 mu in phase II. It mainly produces small varieties of amino acids and human API products. After more than a year of planning and design, the first phase of the project has been started in mid February 2019.The company has a joint-stock subsidiary, Rizhao Zhongli Thermal Power Co., Ltd., which was registered and established in June 2016. It is a supporting project of the biomedical science and Technology Industrial Park in the development zone. The total investment of the company's phase I project is 250 million yuan. Mr. Gao Xiangyou, chairman of the company, also serves as the general manager of the company, presided over the whole construction process of the project. After more than one year of intense construction, The project was officially put into operation in mid May 2018, ensuring the steam power supply of our company and the whole biomedical industrial park.